• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT)

byDonna LeetandAliya Ramjaun
July 28, 2019
in Chronic Disease, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

The two main surgical options for late-stage medial compartment osteoarthritis of the knee are partial knee replacement (PKR) and total knee replacement (TKR). There is significant variation in choice of approach among surgeons, likely because randomized controlled trials comparing the two approaches have not been performed. In this multicenter, randomized controlled trial, 528 patients with isolated osteoarthritis of the medial compartment of the knee were assigned to PKR or TKR to compare the clinical effectiveness of the two procedures measured by the Oxford Knee Score (OKS) 5 years after randomization. The OKS is a patient self-reported outcome questionnaire that was specifically developed to assess function and pain after knee replacement surgery. Health-care costs and cost-effectiveness were also assessed. Researchers found no difference in OKS between the two study groups at 5 years (mean difference 1.04, 95% CI -0.42 to 2.50; p=0.159). Moreover, there was no difference in patient satisfaction between the two groups at 5 years (82% satisfied with knee in PKR group vs. 77% in TKR group, RR 1.06, 95% CI 0.99 to 1.13, p=0.097). Patients receiving TKR had more complications than those receiving PKR (27% vs. 20%, respectively, RR 0.72, 95% CI 0.53 to 0.98; p=0.036). Finally, researchers found that PKR was more effective (0.240 additional QALYs as compared to TKR, 95% CI 0.046 to 0.434) and less expensive (-910£, 95% CI -1503£ to -317£) than TKR during the 5 years of follow-up. Limitations of this study include the absence of masking and the fact that the number of participants who completed follow-up was slightly less than the target of 500 participants required to reach adequate power. In summary, this study indicates that both TKR and PKR offer similar clinical outcomes, but overall suggests that PKR should be considered the first choice for patients with late-stage isolated medial compartment osteoarthritis given its superior cost-effectiveness.

Click to read the study in Lancet

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

Very-low-calorie diets versus exercise alone for the treatement of hip osteoarthritis

Tags: knee replacementorthopedicsosteoarthritispartial knee replacementtotal knee replacement
Previous Post

Quick Take: Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older

Next Post

#VisualAbstract: Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

RelatedReports

Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis
StudyGraphics

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

August 25, 2025
Shorter hospital stays after hip fracture linked to greater risk of short-term death
Orthopedic Surgery

Very-low-calorie diets versus exercise alone for the treatement of hip osteoarthritis

August 4, 2025
Chronic Disease

Physical therapy vs. glucocorticoid injection in patients with meniscal tears and knee osteoarthritis

May 15, 2025
Next Post
#VisualAbstract: Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

#VisualAbstract: Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

Poverty, preterm birth demonstrate additive effect on cognition

Differences in NICU quality and access leads to racial disparities in neonatal outcomes

2 Minute Medicine Rewind July 29, 2019

2 Minute Medicine Rewind July 29, 2019

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis
  • Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs
  • 2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.